FIGS (FIGS) to Release Quarterly Earnings on Thursday

FIGS (NYSE:FIGS) is projected to post its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect FIGS to post earnings of $0.0673 per share and revenue of $186.1730 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

FIGS (NYSE:FIGS) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. FIGS had a return on equity of 9.69% and a net margin of 6.10%.The business had revenue of $159.90 million during the quarter, compared to the consensus estimate of $153.15 million. FIGS’s revenue was up 28.0% on a year-over-year basis. On average, analysts expect FIGS to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

FIGS Stock Performance

Shares of FIGS stock opened at $10.87 on Wednesday. The firm has a market cap of $1.82 billion, a PE ratio of 49.42 and a beta of 1.03. The business’s 50 day simple moving average is $10.93 and its 200 day simple moving average is $12.50. FIGS has a 52-week low of $6.07 and a 52-week high of $17.48.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on FIGS. Zacks Research downgraded shares of FIGS from a “strong-buy” rating to a “hold” rating in a report on Friday, May 8th. BTIG Research restated a “buy” rating and set a $20.00 target price on shares of FIGS in a report on Friday, April 24th. Weiss Ratings downgraded shares of FIGS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 13th. Morgan Stanley lifted their price target on shares of FIGS from $8.00 to $15.00 and gave the company an “equal weight” rating in a research note on Monday, April 13th. Finally, KeyCorp reissued an “overweight” rating on shares of FIGS in a research report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $15.93.

Institutional Investors Weigh In On FIGS

Several large investors have recently made changes to their positions in FIGS. Marshall Wace LLP increased its holdings in FIGS by 66.2% during the fourth quarter. Marshall Wace LLP now owns 4,297,868 shares of the company’s stock worth $48,824,000 after buying an additional 1,712,610 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in FIGS by 2,139.7% in the second quarter. BNP Paribas Financial Markets now owns 1,307,468 shares of the company’s stock valued at $7,374,000 after acquiring an additional 1,249,091 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in FIGS by 9.0% in the second quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock valued at $78,602,000 after acquiring an additional 1,144,962 shares during the last quarter. Squarepoint Ops LLC grew its position in shares of FIGS by 940.7% in the 2nd quarter. Squarepoint Ops LLC now owns 924,092 shares of the company’s stock valued at $5,212,000 after acquiring an additional 835,300 shares during the period. Finally, Woodline Partners LP bought a new position in shares of FIGS in the 1st quarter valued at about $3,199,000. Institutional investors and hedge funds own 92.21% of the company’s stock.

About FIGS

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.